Literature DB >> 35518821

Facial diplegia with paresthesia associated with anti-GD1a antibodies.

Jason Strawbridge1, Katherine A Fu2, Joy Chan3, William Flavin2, Joss Cohen2, Inna Keselman2, Perry Shieh2.   

Abstract

A 26-year-old previously healthy man presented with progressive facial diplegia and sensory deficits to pinprick in a stocking-glove distribution. Lumbar puncture revealed cytoalbuminologic dissociation, and a nerve conduction study of the right facial nerve demonstrated a proximal demyelinating process. He was started on intravenous immunoglobulin given concern for a Guillain-Barré syndrome variant, and his symptoms improved over several days. This case illustrates the clinical features of facial diplegia with paresthesias, a rare variant of Guillain-Barré syndrome. Unlike most reported cases of facial diplegia with paresthesias that have demonstrated positive anti-ganglioside M2 antibodies, this case is unique given the positivity of anti-ganglioside D1a IgG/IgM antibodies.
Copyright © 2022 Baylor University Medical Center.

Entities:  

Keywords:  Anti-ganglioside antibodies; Guillain-Barré syndrome; demyelinating disease; facial diplegia; peripheral neuropathy; polyneuropathy

Year:  2022        PMID: 35518821      PMCID: PMC9037508          DOI: 10.1080/08998280.2022.2043679

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  5 in total

Review 1.  Guillain-Barré syndrome.

Authors:  Nobuhiro Yuki; Hans-Peter Hartung
Journal:  N Engl J Med       Date:  2012-06-14       Impact factor: 91.245

2.  When is facial diplegia regarded as a variant of Guillain-Barré syndrome?

Authors:  J K Kim; S Y Oh; E H Sohn; Y H Hong; S M Jun; J S Bae
Journal:  J Peripher Nerv Syst       Date:  2015-03       Impact factor: 3.494

3.  Guillain-Barré syndrome variant with facial diplegia and paresthesias associated with IgM anti-GalNAc-GD1a antibodies.

Authors:  Ryuichiro Hayashi; Shigeki Yamaguchi
Journal:  Intern Med       Date:  2015       Impact factor: 1.271

4.  Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome.

Authors:  T W Ho; H J Willison; I Nachamkin; C Y Li; J Veitch; H Ung; G R Wang; R C Liu; D R Cornblath; A K Asbury; J W Griffin; G M McKhann
Journal:  Ann Neurol       Date:  1999-02       Impact factor: 10.422

5.  A Guillain-Barré syndrome variant with prominent facial diplegia.

Authors:  Keiichiro Susuki; Michiaki Koga; Koichi Hirata; Emiko Isogai; Nobuhiro Yuki
Journal:  J Neurol       Date:  2009-07-25       Impact factor: 6.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.